Clinical Trial Update: Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study [Phase 2]

View source ↗

Summary

A Phase 2 trial update describing a randomized study of Adebrelimab with induction chemotherapy or SHR-8068 in locally advanced dMMR/MSI-H gastric and gastroeso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• SHR-8068

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING